Table 3.
iRANO | 12 Months: n (%) | 18 Months: n (%) | 24 Months: n (%) |
---|---|---|---|
Complete response | 4 (13.3) | 5 (16.7) | 2 (6.7) |
Partial response | 2 (6.7) | 0 (0) | 0 (0) |
Stable disease | 3 (10.0) | 0 (0) | 0 (0) |
Disease progression | 19 (63.3) | 23 (76.7) | 26 (86.7) |